This story was corrected on January 17 to more accurately reflect Packard BioScience’s microarray strategy. The company has cancelled plans to sell DNA chips, not microarrays, as previously reported.

SAN FRANCISCO, Jan 8 – Packard BioScience has cancelled plans to commercialize DNA chips after determining that Affymetrix’ domination in the market was too formidable, a company spokesman said Monday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Though many details have yet to be worked out, the draft deal for the UK's withdrawal from the EU is giving researchers some hints for what they can expect, Nature News says.

DNA testing has solved a 100-year-old mystery contained in the skull and teeth samples of a now-extinct monkey that once inhabited Jamaica, Gizmodo reports.

As the UN ponders a ban on gene drives, one malaria researcher says there are less dramatic ways to fight the disease in Africa than unleashing GM mosquitoes on a whole continent.

In Nature this week: an improved reference genome of the Aedes aegypti mosquito, genomes of four species of truffles, and more.